Hemostatic changes in thyroid diseases

Hematology

Volumn 11, Issue 3, 2006, Pages 203-208

  Franchini, Massimo ^a  

^a UNIVERSITY HOSPITAL OF VERONA   (Italy)

Author keywords

Bleeding; Hemostasis; Hyperthyroidism; Hypothyroidism; Thrombosis; Thyroid

Indexed keywords

ANTICOAGULANT AGENT; ANTITHYROID AGENT; BLOOD CLOTTING FACTOR; CYCLOPHOSPHAMIDE; LEVOTHYROXINE; METHYLPREDNISOLONE; THYROID HORMONE; WARFARIN;

BLEEDING; BLEEDING TENDENCY; BLOOD CLOTTING DISORDER; CLINICAL PROTOCOL; DISEASE SEVERITY; DRUG MEGADOSE; FIBRINOLYSIS; GRAVES DISEASE; HEMOSTASIS; HUMAN; HYPERCOAGULABILITY; HYPERTHYROIDISM; HYPOTHYROIDISM; IMMUNE SYSTEM; PRIORITY JOURNAL; REVIEW; RISK ASSESSMENT; THROMBOSIS; THYROID CANCER; THYROID DISEASE;

BLOOD COAGULATION DISORDERS; BLOOD COAGULATION FACTORS; HEMORRHAGIC DISORDERS; HEMOSTASIS; HUMANS; HYPERTHYROIDISM; HYPOTHYROIDISM; THROMBOPHILIA; THYROID DISEASES; THYROID HORMONES; THYROID NEOPLASMS; VON WILLEBRAND DISEASE; VON WILLEBRAND DISEASES;

EID: 33748481342     PISSN: 10245332     EISSN: 16078454     Source Type: Journal    
DOI: 10.1080/10245330600667591     Document Type: Review

References (93)

1. Simone, JV and Abildgaard, CF and Schulman, I. (1965) Blood coagulation in thyroid dysfunction N Engl J Med, 273, pp. 1057-1061.
2. Myrup, B and Bregengård, C and Faber, J. (1995) Primary haemostasis and thyroid disease J Intern Med, 238, pp. 59-63.
3. Hofbauer, LC and Heufelder, AE. (1997) Coagulation disorders in thyroid diseases Eur J Endocrinol, 136, pp. 1-7.
4. Rennie, JA and Bewsher, PD and Murchison, LE and Ogston, E. (1978) Coagulation and fibrinolysis in thyroid disease Acta Haematol, 58, pp. 171-177.
5. Franchini, M. (2004) Hemostasis and thyroid diseases revisited J Endocrinol Invest, 27, pp. 886-892.
6. Marongiu, F and Cauli, C and Mariotti, S. (2004) Thyroid, hemostasis and thrombosis J Endocrinol Invest, 27, pp. 1065-1071.
7. Ford, HC and Carter, JM. (1990) Haemostasis in hypothyroidism Postgrad Med J, 66, pp. 280-284.
8. Erem, C and Kavgaci, H and Ersöz, H and (2003) Blood coagulation and fibrinolytic activity in hypothyroidism Int J Clin Pract, 57, pp. 78-81.
9. Savage, RA and Sipple, C. (1975) Marrow myxedema Arch Pathol Lab Med, 111, pp. 375-377.
10. Berchtold, P and Harris, JP and Tani, P and Piro, L and McMillan, R. (1989) Autoantibodies to platelet glycoproteins in patients with disease-related immune thrombocytopenia Br J Haematol, 73, pp. 365-368.
11. Hymes, K and Blum, M and Lackner, H and Karpatkin, S. (1981) Easy bruising, thrombocytopenia, and elevated platelet immunoglobulin G in Graves' disease and Hashimoto's thyroiditis Ann Intern Med, 94, pp. 27-30.
12. Lamberg, BA and Kivikangas, V and Pelkonen, R. (1971) Thrombocytopenia and decreased life-span of thrombocytes in hyperthyroidism Ann Clin Res, 3, pp. 98-102.
13. Marshall, JS and Weisberger, AS and Levy, RP. (1967) Coexistent idiopathic thrombocytopenic purpura and hyperthyroidism Ann Intern Med, 67, pp. 411-414.
14. Kurata, Y and Nishioeda, Y and Tsubakio, T and Kitani, T. (1980) Thrombocytopenia in Graves' disease: Effect of T3 on platelet kinetics Acta Haematol, 63, pp. 185-190.
15. Panzer, S and Haubenstock, A and Minar, E. (1990) Platelets in hyperthyroidism: Studies on platelet counts, mean platelet volume, 111indium labeled platelet kinetics and platelet associated immunoglobulins G and M J Clin Endocrinol Metab, 70, pp. 491-496.
16. Bizzaro, N. (1992) Familial association of autoimmune thrombocytopenia and hyperthyroidism Am J Hematol, 39, pp. 294-298.
17. Adrouny, A and Sandler, R and Carmel, R. (1982) Variable presentation of thrombocytopenia in Graves' disease Arch Intern Med, 142, pp. 1460-1464.
18. Pinals, RS and Tomar, RH and Haas, DC and Farah, F. (1977) Graves' disease, myasthenia gravis and purpura Ann Intern Med, 87, pp. 250.
19. Yamaguchi, K and Ookubo, Y and Matsuda, H and Suzaki, K and Fujushima, H and Uzwa, H. (1987) Idiopathic thrombocytopenic purpura subsequent to Graves' disease and insulin-dependent diabetes mellitus Diabetes Res Clin Pract, 3, pp. 233-237.
20. Lio, S and Albin, M and Girelli, G and (1993) Abnormal thyroid function test results in patients with Fisher Evans syndrome J Endocrinol Invest, 16, pp. 163-167.
21. Crabtree, GR and Lee, JC and Cornwell, GG. (1975) Autoimmune thrombocytopenic purpura and Hashimoto's thyroiditis Ann Intern Med, 83, pp. 371-372.
22. Ho, SL and Shah, M and Williams, AC. (1992) Idiopathic thrombocytopenic purpura and autoimmune thyroiditis in a patient with myasthenia gravis Muscle Nerve, 15, pp. 966-967.
23. Segal, BM and Weintraub, MI. (1976) Hashimoto's thyroiditis, myasthenia gravis, idiopathic thrombocytopenic purpura Ann Intern Med, 85, pp. 761-763.
24. Cordiano, I and Betterle, C and Spadaccino, CA and Soini, B and Girolami, A and Fabris, F. (1998) Autoimmune thrombocytopenia (AITP) and thyroid autoimmune disease (TAD): Overlapping syndromes? Clin Exp Immunol, 113, pp. 373-378.
25. Hofbauer, LC and Spitzweg, C and Schmauss, S and Heufelder, AE. (1997) Graves disease associated with autoimmune thrombocytopenic purpura Arch Intern Med, 157, pp. 1033-1036.
26. Zeigler, ZR and Hasiba, U and Lewis, JH and Vagnucci, AH and West, VA and Bezek, EA. (1986) Hemostatic defects in response to aspirin challenge in hypothyroidism Am J Hematol, 17, pp. 209-215.
27. Hellem, AJ and Segaard, E and Solem, JH. (1975) The adhesiveness of human blood platelets and thyroid function Acta Med Scand, 197, pp. 15-17.
28. Edson, JR and Fecher, DR and Doe, RP. (1975) Low platelet adhesiveness and other abnormalities in hypothyroidism Ann Intern Med, 82, pp. 342-346.
29. Palareti, G and Biagi, G and Legnani, C and (1989) Association of reduced factor VIII with impaired platelet reactivity to adrenalin and collagen after total thyroidectomy Thromb Haemost, 62, pp. 1053-1056.
30. Rogers, JS and Shane, SR and Jencks, FS. (1982) Factor VIII activity and thyroid function Ann Intern Med, 97, pp. 713-716.
31. Rogers, JS and Shane, SR. (1983) Factor VIII activity in normal volunteers receiving oral thyroid hormone J Lab Clin Med, 102, pp. 444-449.
32. Gullu, S and Sav, H and Kamel, N. (2005) Effects of levothyroxine treatment on biochemical and hemostasis parameters in patients with hypothyroidism Eur J Endocrinol, 152, pp. 355-361.
33. Dalton, RG and Dewar, MS and Savidge, GF and (1987) Hypothyroidism as a cause of acquired von Willebrand's disease Lancet, 1, pp. 1007-1009.
34. Smith, SR and Anger, MJ. (1987) Hypothyroidism and von Willebrand's disease Lancet, 1, pp. 1314.
35. MacCallum, PK and Rodgers, M and Taberner, DA. (1987) Hypothyroidism and von Willebrand's disease Lancet, 1, pp. 1314.
36. Thornton, JG and Parapia, LA and Minford, AMB. (1987) Hypothyroidism and von Willebrand's disease Lancet, 1, pp. 1314-1315.
37. Nitu-Whalley, IC and Lee, CA. (1999) Acquired von Willebrand syndrome - report of 10 cases and review of the literature Haemophilia, 5, pp. 318-326.
38. Michiels, JJ and Schroyens, W and Berneman, Z and van der Planken, M. (2001) Acquired von Willebrand syndrome type 1 in hypothyroidism: Reversal after treatment with thyroxine Clin Appl Thromb Hemost, 7, pp. 113-115.
39. Franchini, M and de Gironcoli, M and Lippi, G and (2002) Efficacy of desmopressin as surgical prophylaxis in patients with acquired von Willebrand disease undergoing thyroid surgery Haematologica, 8, pp. 142-144.
40. Petrini, P. (1999) Acquired von Willebrand disease Haemophilia, 5(Suppl. 2), pp. 68-69.
41. Attivissimo, LA and Lichtman, SM and Klein, I. (1995) Acquired von Willebrand's syndrome causing a hemorrhagic diathesis in a patient with hypothyroidism Thyroid, 5, pp. 399-401.
42. Blesing, NE and Hambley, H and McDonald, GA. (1990) Acquired von Willebrand's disease and hypothyroidism: Report of a case presenting with menorrhagia Postgrad Med J, 66, pp. 474-476.
43. Bruggers, CS and McElligott, K and Rallison, ML. (1994) Acquired von Willebrand disease in twins with autoimmune hypothyroidism: Response to desmopressin and l-thyroxine therapy J Pediatr, 125, pp. 911-913.
44. Levesque, H and Borg, JY and Cailleux, N and (1993) Acquired von Willebrand's syndrome associated with decrease of plasminogen activator and its inhibitor during hypothyroidism Eur J Med, 2, pp. 287-288.
45. Rinder, MR and Richard, RE and Rinder, HM. (1997) Acquired von Willebrand's disease: A concise review Am J Hematol, 54, pp. 139-145.
46. Aylesworth, C and Smallridge, RC and Rick, ME and Alving, BM. (1995) Acquired von Willebrand's disease: A rare manifestation of postpartum thyroiditis Am J Hematol, 50, pp. 217-219.
47. Tjan-Heijnen, VCG and Harthoorn-Lasthuizen, EJ and Kurstjens, RMA and Koolen, MI. (1994) A patient with postpartum primary hypothyroidism and acquired von Willebrand's disease Neth J M, 44, pp. 91.
48. Soni, S and Singh, G and Yasir, S and Hatipoglu, B. (2005) An unusual presentation of hypothyroidism Thyroid, 15, pp. 289-291.
49. Franchini, M and Veneri, D and Lippi, G. (2005) Analysis of thyroid hormone status in 131 consecutive individuals with low von Willebrand factor levels Thromb Haemost, 93, pp. 392-393.
50. Meiklejohn, DJ and Watson, HG. (2001) Acquired haemophilia in association with organ-specific autoimmune disease Haemophilia, 7, pp. 523-525.
51. Graninger, W and Pirich, KR and Speiser, W and Deutsch, E and Waldháusl, WK. (1986) Effect of thyroid hormones on plasma protein concentration in man J Clin Endocrinol Metab, 63, pp. 407-411.
52. Erfuth, EM and Ericsson, U-B and Egervall, K and Lethagen, SR. (1995) Effect of desmopressin and long-term thyroxine replacement on haemostasis in hypothyroidism Clin Endocrinol (Oxf), 42, pp. 373-378.
53. Van Oosterom, AT and Kerkhoven, P and Veltkamp, JJ. (1979) Metabolism of the coagulation factors of the prothrombin complex in hypothyroidism in man Thromb Haemost, 41, pp. 273-285.
54. De Feo, P. (1996) Hormonal regulation of human protein metabolism Eur J Endocrinol, 135, pp. 7-18.
55. Egeberg, BO. (1963) Influence of thyroid function on the blood clotting system Scand J Clin Lab Invest, 15, pp. 1-7.
56. Nordoy, A and Vikmo, H and Berntsen, H. (1976) Haemostatic and lipid abnormalities in hypothyroidism Scand J Haematol, 16, pp. 154-160.
57. Farid, NR and Griffiths, BL and Collins, JR and Marshall, WH and Ingram, DW. (1976) Blood coagulation and fibrinolysis in thyroid disease Thromb Haemost, 35, pp. 415-422.
58. Marongiu, F and Conti, M and Murtas, ML and Mameli, G and Sorano, GG and Martino, E. (1991) Activation of blood coagulation in Graves' disease Horm Metab Res, 23, pp. 609-611.
59. Erem, C and Ersöz, H and Karti, SS and (2002) Blood coagulation and fibrinolysis in hyperthyroidism J Endocrinol Invest, 25, pp. 345-350.
60. Marongiu, F and Cauli, C and Mameli, G and Usai, B and Mariotti, S. (2002) Apatehtic Graves' disease and acquired hemophilia due to factor VIIIc antibody J Endocrinol Invest, 25, pp. 246-249.
61. Sievert, R and Goldstein, ML and Surks, MI. (1996) Graves' disease and autoimmune factor VIII deficiency Thyroid, 6, pp. 245-247.
62. Rosen, IB and Anderson, I and Musclow, CE. (1986) The factor of factor XI deficiency in thyroid neoplasia Surgery, 100, pp. 1062-1067.
63. Müller, B and Tsakiris, DA and Roth, CB and Guglielmetti, M and Staub, JJ and Marbet, GA. (2001) Haemostatic profile in hypothyroidism as potential risk for vascular or thrombotic disease Eur J Clin Invest, 31, pp. 131-137.
64. Marongiu, F and Biondi, G and Conti, M and (1992) Is a hypercoagulable state present in hypothyroidism? Thromb Haemost, 67, pp. 729.
65. Hak, AE and Pols, HA and Visser, TJ and Drexhage, HA and Hofman, A and Witteman, JC. (2000) Subclinical hypothyroidism is an independent risk factor for atherosclerosis and myocardial infarction in elderly women: The Rotterdam study Ann Intern Med, 132, pp. 270-278.
66. Chadaverian, R and Bruckert, E and Ankri, A and Beucler, I and Giral, P and Turpin, G. (1998) Relationship between thyroid hormones and plasma D-dimer levels Thromb Haemost, 79, pp. 99-103.
67. Fowkes, FGR and Lowe, GDO and Housley, E and (1993) Cross-linked fibrin degradation products, progression of peripheral arterial disease, and risk of coronary heart disease Lancet, 342, pp. 84-86.
68. Thompson, SG and Kienast, J and Pyke, SD and Haverkate, F and van de Loo, JC. (1995) Hemostatic factors and the risk of myocardial infarction or sudden death in patients with angina pectoris. European Concerted Action on Thrombosis and Disabilities Angina Pectoris Study Group N Engl J Med, 322, pp. 635-641.
69. Chadarevian, R and Bruckert, E and Leenhardt, L and Giral, P and Ankri, A and Turpin, G. (2001) Components of the fibrinolytic system are differently altered in moderate and severe hypothyroidism J Clin Endocrinol Metab, 86, pp. 732-737.
70. Chadarevian, R and Jublanc, C and Bruckert, E and (2005) Effect of levothyroxine replacement therapy on coagulation and fibrinolysis in severe hypothyroidism J Endocrinol Invest, 28, pp. 398-404.
71. Guldiken, S and Demir, M and Turgut, B and Altun, BU and Arikan, E and Kara, M. (2005) Global fibrinolytic capacity in patients with subclinical hypothyroidism Endocr J, 52, pp. 363-367.
72. Özcan, MA and Çömlekçi, A and Demrkan, F and (2003) Plasma levels of free tissue factor pathway inhibitor in patients with various thyroid disorders Thromb Res, 110, pp. 243-247.
73. Catargi, B and Parrot-Roulaud, F and Cochet, C and Ducassou, D and Roger, P and Tabarin, A. (1999) Homocysteine, hypothyroidism, and effect of thyroid hormone replacement Thyroid, 9, pp. 1163-1166.
74. Marongiu, F and Conti, M and Murtas, ML and (1991) Anticardiolipin antibodies in Grave's disease: Relationship with thrombin activity in vivo Thromb Res, 64, pp. 745-749.
75. Paggi, A and Caccavo, D and Ferri, GM and (1994) Anticardiolipin antibodies in autoimmune thyroid disease Clin Endocrinol, 40, pp. 329-333.
76. Hofbauer, LC and Spitzweg, C and Heufelder, AE. (1996) Graves' disease associated with the primary antiphospholipid syndrome J Rheumatol, 23, pp. 1435-1437.
77. Takahashi, A and Tamura, A and Ishikawa, O. (2002) Antiphospholipid antibody syndrome complicated by Graves' disease J Dermatol, 29, pp. 776-780.
78. Osundeko, O and Hasinski, S and Rose, LI. (2001) Anticardiolipin antibodies in Hashimoto's disease Endocr Pract, 7, pp. 181-183.
79. Nabriski, D and Ellis, M and Ness-Abramof, R and Shapiro, M and Shenkman, L. (2000) Autoimmune thyroid disease and antiphospholipid antibodies Am J Hematol, 64, pp. 73-75.
80. Dagenais, P and Urowitz, MB and Gladman, DD and Norman, CS. (1992) A family study of the antiphospholipid syndrome associated with other autoimmune diseases J Rheumatol, 19, pp. 1393-1396.
81. Loeliger, EA and Esch, B. (1963) The biological disappearance rate of prothrombin, factors VII, and X from plasma in hypothyroidism, hyperthyroidism, and during fever Thromb Diathes Haemorrh, 10, pp. 267-277.
82. Kellet, HA and Sawers, JSA and Boulton, FE and Cholerton, S and Park, BK and Toft, AD. (1986) Problems of anticoagulation with warfarin in hyperthyroidism Q Med J, 58, pp. 43-51.
83. Burggraaf, J and Lalezari, S and Emeis, JJ and (2001) Endothelial function in patients with hyperthyroidism before and after treatment with propranolol and thiamazol Thyroid, 2, pp. 153-160.
84. Liu, L and Wang, X and Lin, Z and Wu, H. (1993) Elevated plasma levels of vWF: Ag in hyperthyroidism are mediated through beta-adrenergic receptors Endocrine Res, 19, pp. 123-133.
85. Morikawa, Y and Morikawa, A and Makino, I. (1993) Relationship of thyroid states and serum thrombomodulin (TM) levels in patients with Grave's disease: TM a possible new marker of the peripheral activity of thyroid hormones J Clin Endocrinol Metab, 76, pp. 609-614.
86. Chen, YL and Tan, J and Wang, X and Liang, H and Sun, X. (1998) Impaired release of tissue plasminogen activator from the endothelium in Graves' disease - indicator of endothelial dysfunction and reduced fibrinolytic capacity Eur J Clin Invest, 28, pp. 1050-1054.
87. Morishita, E and Hashimoto, T and Asakura, H and (1998) Increased plasma levels of free tissue factor pathway inhibitor in patients with Graves' disease Thromb Haemost, 79, pp. 919-923.
88. Chadaverian, R and Bruckert, E and Giral, P and Turpin, G. (1999) Relationship between thyroid hormones and fibrinogen levels Blood Coagul Fibrinolysis, 10, pp. 481-486.
89. Grant, PJ and Medcalf, RL. (1990) Hormonal regulation of haemostasis and the molecular biology of the fibrinolytic system Clin Sci, 78, pp. 3-11.
90. Marongiu, F and Conti, M and Mameli, G and (1988) Fibrinogen and fibrinolytic activity in hyperthyroidism before and after antithyroid treatment J Endocrinol Invest, 11, pp. 723-725.
91. Tiede, DJ and Tefferi, A and Kochhar, R and Thompson, GB and Hay, ID. (1994) Paraneoplastic cholestasis and hypercoagulability associated with medullary thyroid carcinoma Cancer, 73, pp. 702-705.
92. Raveh, E and Cohen, M and Shpitzer, T and Feinmesser, R. (1995) Carcinoma of the thyroid: A cause of hypercoagulability? Ear Nose Throat J, 74, pp. 110-112.
93. Sagripanti, A and Carpi, A and Baicchi, U. (1991) The measurement of plasma D-dimer in the follow-up after thyroidectomy for cancer: Preliminary data Thyroidol, 3, pp. 31-35.